Relationship between cardiovascular risk factors and adipokines in adolescents

Hormone Research in Paediatrics

Volumn 76, Issue 2, 2011, Pages 123-129

  Rubin, Daniela A ^a,b   McMurray, Robert G ^a   Hackney, Anthony C ^a   Harrell, Joanne S ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Adolescents; Blood pressure; Cytokines; Lipids; Obesity

Indexed keywords

ADIPOCYTOKINE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OBESITY; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPOKINES; ADIPONECTIN; ADOLESCENT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHILD; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; HUMANS; INTERLEUKIN-6; MALE; OVERWEIGHT; REGRESSION ANALYSIS; RESISTIN; RISK FACTORS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE;

EID: 84860397251     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000327852     Document Type: Article

References (36)

1. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
2. Sinaiko AR, Steinberger J, Moran A, Hong CP, Prineas RJ, Jacobs DR Jr: Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension 2006; 48: 730-736.
3. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374.
4. Williams DE, Cadwell BL, Cheng YJ, Cowie CC, Gregg EW, Geiss LS, Engelgau MM, Narayan KM, Imperatore G: Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics 2005; 116: 1122-1126.
5. Van Gaal LF, Mertens IL, Block CD: Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-880.
6. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
7. Hajer GR, van Haeften TW, Visseren FL: Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29: 2959-2971.
8. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288-1295.
9. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
10. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Novel modulator for endothelial adhesion molecules: Adipocyte- derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476.
11. Rubin DA, McMurray RG, Harrell JS, Hackney AC, Thorpe DE, Haqq AM: The association between insulin resistance and cytokines in adolescents: The role of weight status and exercise. Metabolism 2008; 57: 683-690.
12. Chu NF, Shen MH, Wu DM, Lai CJ: Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children. Obes Res 2005; 13: 2014-2020.
13. Huang KC, Chen CL, Chuang LM, Ho SR, Tai TY, Yang WS: Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab 2003; 88: 4130-4134.
14. Moon YS, Kim DH, Song DK: Serum tumor necrosis factor-αlevels and components of the metabolic syndrome in obese adolescents. Metabolism 2004; 53: 863-867.
15. Barbieri M, Ferrucci L, Corsi AM, Macchi C, Lauretani F, Bonafé M, Olivieri F, Giovagnetti S, Franceschi C, Paolisso G: Is chronic inflammation a determinant of blood pressure in the elderly? Am J Hypertens 2003; 16: 537-543.
16. Gerber M, Boettner A, Seidel B, Lammert A, Bar J, Schuster E, Thiery J, Kiess W, Kratzsch J: Serum resistin levels of obese and lean children and adolescents: Biochemical analysis and clinical relevance. J Clin Endocrinol Metab 2005; 90: 4503-4509.
17. Harrell JS, McMurray RG, Gansky SA, Bangdiwala SI, Bradley CB: A public health versus a risk-based intervention to improve cardiovascular health in elementary school children: The Cardiovascular Health in Children Study. Am J Public Health 1999; 89: 1529-1535.
18. McMurray R, Harrell J, Bangdiwala S: A school-based intervention can reduce body fat and blood pressure in young adolescents. J Adolesc Health 2002: 31: 125-132.
19. Centers for Disease Control and Prevention National Centers for Health Statistics. CDC Growth Charts: United States, May 30, 2000 ().http://www.cdc. gov/growthcharts
20. United States Department of Human and Health Services. NHANES III Reference Manuals and Reports; in National Center for Health Statistics. Hyattsville, MD, CDC Prevention, 1996.
21. Petersen AC, Crockett L, Richards M: A selfreport measure of pubertal status: Reliability, validity, and initial norms. J Youth Adolesc; 1988; 17: 117-133.
22. Chan DC, Watts GF, Ng TW, Uchida Y, Sakai N, Yamashita S, Barrett P: Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin Chem 2005; 51: 578-585.
23. Li JJ, Li YS, Chu JM, Zhang CY, Wang Y, Huang Y, Chen J, Yuang JQ, Huang Y: Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia. Clin Chem Acta 2006; 366: 269-273.
24. Norata G, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano A: Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 2007; 156: 279-284.
25. Bacha F, Saad R, Gungor N, Arslanian SA: Adiponectin in youth: Relationship to visceral adiposity, insulin sensitivity, and -cell function. Diabetes Care 2004; 27: 547-552.
26. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002; 277: 25863-25866.
27. Gilardini L, Parati G, Sartorio A, Mazzilli G, Pontiggia B, Invitti C: Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens 2008; 22: 75-82.
28. De Ferranti S, Mozaffarian D: The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54: 945-955.
29. Huang KC, Lue BH, Yen RF, Shen CG, Ho SR, Tai TY, Yang WS: Plasma adiponectin levels and metabolic factors in nondiabetic adolescents. Obes Res 2004; 12: 119-124
30. Chan DC, Barrett PH, Watts GF: Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders. Curr Opin Lipidol 2006; 17: 28-36.
31. Singhai NS, Patel RT, Qi Y, Lee Y-S, Ahima R: Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am J Physiol Endocrinol Metab 2008; 295:E331-E338.
32. Belcher JD, Ellison RC, Shepard WE, Bigelow C, Webber LS, Wilmore JH, Parcel GS, Zucker DM, Luepker RV: Lipid and lipoprotein distributions in children by ethnic group, gender, and geographic locationpreliminary findings of the Child and Adolescent Trial for Cardiovascular Health (CATCH). Prev Med 1993; 22: 143-153.
33. Carvalho GQ, Pereira PF, Serrano HM, do Carmo Castro Franceschini S, Oliveira de Paula S, Priore SE, do Carmo Gouveia Peluzio M: Peripheral expression of inflammatory markers in overweight female adolescents and eutrophic female adolescents with a high percentage of body fat. Appl Physiol Nutr Metab 2010; 35: 464-70.
34. Rubin DA, McMurray RG, Harrell JS, Hackney AC, Haqq AM: Do surrogate markers for adiposity relate to cytokines in adolescents? J Investig Med 2008; 56: 786-792.
35. Petersen AM, Pedersen BK: The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 1154-1162.
36. Trayhurn P, Wood IS: Signaling role of adipose tissue: Adipokines and inflammation in obesity. Biochem Soc Trans 2005; 33: 1078-1081.